NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...

As Pfizer races to grow the respiratory syncytial virus (RSV) vaccine market along with rival GSK, the company has been looking to expand its vaccine's reach. Now, armed with fresh data for Abrysvo in ...

GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.

Abrysvo has the potential to become the first and only RSV vaccine for adults 18 years and older. Participants demonstrated RSV-A and RSV-B subgroup-neutralizing responses that were non-inferior to ...

(RTTNews) - Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration approved ABRYSVO (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F or RSVpreF vaccine, ...

(RTTNews) - The U.S. Food and Drug Administration announced the approval of Pfizer Inc.'s Abrysvo (Respiratory Syncytial Virus Vaccine) for use in pregnant individuals to prevent respiratory syncytial ...

The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo has been approved as a maternal vaccine to ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...

Already with an approval in hand for older adults, Pfizer’s Abrysvo has become the first vaccine for pregnant women to protect their newborns against respiratory syncytial virus (RSV). The FDA has ...

Expectant parents could soon have another new option this fall to protect their newborns from RSV, or respiratory syncytial virus, the most common cause of hospitalization in American infants, after ...

(RTTNews) - The European Commission approved Pfizer Inc.'s (PFE) Abrysvo to help protect infants through maternal immunization and older adults from respiratory syncytial virus or RSV. It is the first ...